A proximity-induced chimera platform for targeted protein arginine methylation.
- Author:
Yanlin JIAN
1
;
Tianyang ZHOU
1
;
Chendong GUO
1
;
Yibo GAO
1
;
Chen YAO
1
;
Zixi WANG
1
;
Xuehan JIANG
1
;
Ke WANG
1
;
Jian MA
1
;
Yang GAO
1
;
Yizeng FAN
1
;
Jing LIU
1
;
Bohan MA
1
;
Lei LI
1
Author Information
- Publication Type:Journal Article
- Keywords: AKT; Androgen receptor; Arginine methylation; Bifunctional molecules; Methylation tagging system; P300; Protein arginine methyltransferases; Ternary complex
- From: Acta Pharmaceutica Sinica B 2025;15(5):2625-2639
- CountryChina
- Language:English
- Abstract: Arginine methylation is a critical post-translational modification that plays multifaceted biological functions. However, the manipulation of protein arginine methylation largely depends on genetic or pharmaceutic inhibition of the regulatory enzymes, protein arginine methyltransferases (PRMTs), or non-methylation substitution of corresponding arginine residue to lysine or alanine of protein of interest (POI), which inevitably affects other substrates, or disrupts the structure of POI. Thus, it urges an approach to specifically modulate the arginine methylation of a POI under physiological conditions. To this end, we report the discovery of a methylation tagging system (MeTAG), that enables targeted modification of protein arginine methylation. Through bridging the methyltransferase PRMT5 proximity to a POI, MeTAG facilitates the arginine methylation of POIs, including known arginine methylated proteins, androgen receptor (AR) and protein kinase B (AKT), as well as a neo-substrate E1A binding protein (p300), in a reversible and PRMT5-dependent manner. Moreover, MeTAG can regulate downstream signaling in a methylation dependent manner, leading to downregulation of PSMA mRNA level and activation of AKT. Therefore, MeTAG represents a feasible approach to modulate protein methylation and thereby perturbs protein function in biological and therapeutic contexts.
